Skip to content

Assesment of antioxidant status in vivo and in vitro of guarana (Paullinia cupana).

Effects of ingestion of a beverage made with guarana powder on plasma and low density lipoprotein (LDL) susceptibility to oxidation and on antioxidant enzymes status in overweight adults

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000758202
Enrollment
15
Registered
2009-09-01
Start date
2009-09-18
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The aim of this study is to investigate a short and a long term effects of the consumption of a beverage made with guarana powder (3g) and water (300ml) on the inhibition of lipid peroxidation on plasma and LDL of overweigth subjects as well as the antioxidant activity of the enzymes Superoxido Dismutase, Catalase and Gluthatione Peroxidase in erytrocitys. Comet Assay will be also perfomed to assess Deoxyribonucleic acid (DNA) volunteers lymphocytes damage before and after the intervention wiht guarana.

Interventions

Twelve (12) overweight volunteers will be instructed to gradually reduce the ingestion of coffee, tea, red wine, chocolate and other foods that contain guarana before 15 days before the visit for the blood collection and during the intervention. Consumption of juice fruits may not exceed 300ml per day and alcoholic beverage will be required to be avoided at least 2 days before each visit. Vollunteers will be asked to avoid taking any antioxidant suplement for 2 weeks beforetheir first visit and

Twelve (12) overweight volunteers will be instructed to gradually reduce the ingestion of coffee, tea, red wine, chocolate and other foods that contain guarana before 15 days before the visit for the blood collection and during the intervention. Consumption of juice fruits may not exceed 300ml per day and alcoholic beverage will be required to be avoided at least 2 days before each visit. Vollunteers will be asked to avoid taking any antioxidant suplement for 2 weeks beforetheir first visit and throughout the ensuing study periods. They will have their blood drawn on a twelve-hour overnight fast (T=1) and one hour after guarana consumption the second blood sample will be collected (T=2). Fifteen days after drinking the beverage made with guarana powder (3g) diluited in cold 300 ml water, two blood samples will be collected: one on a twelve-hour overnight fast (T=3) and other after the fisrt hour of drinking the beverage (T=4). Lipid profile of the volunteers will be evaluated on the begging and in the end of the intervention. Plasma and LDL at the four moments will be submitted to oxidation by copper (Cu+2) and after that the kinetics of diene conjugate generation and thiobarbituric acid reactive substance (TBARS) will be evaluated as well antioxidant activity of the enzymes gluthatione peroxidase (GPx), superoxide dismutase (SOD), and catalase (CAT) in erythrocites. Antioxidant Total Status of the plasma will be determinated. The Deoxyribonucleic acid (DNA) damage will be analyzed in blood lymphocytes using the Comet Assay. The Comet assay successfully assess interactions of antioxidants with genotoxicants and it has also proved a valid technique to evaluate whether antioxidant/micronutrients are able to protect the integrity of the genetic material.

Sponsors

Carolina de Aguiar Martins
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Body Mass Index (BMI).: 24.90 kg/m2 < BMI> 29.90 Kg/m2 (overweight) tryglicerides: < 400mg/dl total cholesterol: <200 mg/dl LDl cholesterol: from 100 to 159 mg/dL

Exclusion criteria

Vegetarian diet, pregnant , smoking, obesity, diabetes, hypertension,chronic heart disease (CHD) history, hepatic desease, regular use of supplements or drugs, sensibility to caffeine or any other chronic desease.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026